Table 2 Comparison of CMR findings between LVEF-recovered and -unrecovered PPCM patients

Age, years

27.5 ± 5.9

29.3 ± 6.0

0.505

BMI (kg/m²)

22.2 ± 2.3

21.9 ± 5.3

0.852

SBP (mmHg)

106.8 ± 9.0

99.7 ± 8.5

0.079

DBP (mmHg)

73.4 ± 12.1

63.3 ± 6.0

0.023

HR (beat/min)

89.2 ± 18.7

83.7 ± 14.6

0.461

NYHA class

0.771

 II/III/ IV, n

2/5/3

1/6/4

 HCT (%)

41.6 ± 3.8

39.5 ± 4.6

0.280

 NT-proBNP (pg/ml)

1451.5 [470.0, 3398.5]

2243.0 [1817.0, 5976.0]

0.387

 TnT(ng/L)

10.1 [2.8, 14.7]

12.5 [7.2, 25.6]

0.236

 LVEDVI (ml/m²)

150.9 ± 24.0

158.1 ± 38.0

0.615

 LVEF (%)

29.3 ± 11.2

24.5 ± 10.1

0.317

 LVMI (g)

70.4 ± 9.3

76.5 ± 21.0

0.405

 RVEDVI (ml/m²)

118.8 ± 38.8

122.5 ± 44.6

0.845

 RVEF (%)

34.3 ± 15.7

33.5 ± 14.4

0.900

 LGE, n (%)

2 (20)

6 (54.5)

0.119

 ECV (%)

30.7 ± 2.1

36.8 ± 5.6

0.005

 Native T1 (ms)

1301 ± 71

1385 ± 66

0.011

 Post T1 (ms)

487 ± 77

418 ± 40

0.018

 T2 (ms)

40.6 ± 3.0

43.9 ± 3.7

0.040

 ACEI/ARB, n (%)

9 (90)

11 (100)

0.476

 β blocker, n (%)

10 (100)

9 (81.8)

0.476

 Antisterone, n (%)

10 (100)

11 (100)

NA

 Diuretic, n (%)

8 (80)

10 (90.9)

0.586